{"id":22736,"date":"2024-02-19T14:40:31","date_gmt":"2024-02-19T13:40:31","guid":{"rendered":"https:\/\/ggba.swiss\/?p=22736"},"modified":"2024-02-19T14:40:32","modified_gmt":"2024-02-19T13:40:32","slug":"atinary-and-takeda-forge-a-strategic-alliance-to-advance-healthcare-innovation","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/en\/atinary-and-takeda-forge-a-strategic-alliance-to-advance-healthcare-innovation\/","title":{"rendered":"Atinary and Takeda forge a strategic alliance to advance healthcare innovation"},"content":{"rendered":"\n<p><a href=\"https:\/\/atinary.com\/\">Atinary Technologies<\/a>, known for its revolutionary Self-Driving Labs (<a href=\"https:\/\/atinary.com\/solutions\/\">SDLabs<\/a>) platform, is at the forefront of integrating machine learning (ML) into the R&amp;D workflows of various industries, including pharmaceuticals. By adopting Atinary\u2019s SDLabs technology, <a href=\"https:\/\/www.takeda.com\/\">Takeda<\/a> aims to refine its drug discovery and development processes, ensuring a more streamlined approach that could significantly shorten the time it takes to bring new therapies to market.<\/p>\n\n\n\n<p>This strategic partnership is set to merge Atinary&#8217;s cutting-edge AI technology with Takeda&#8217;s extensive expertise in pharmaceutical research and development (R&amp;D), promising to fast-track drug discovery and enhance the efficiency of the drug development process.<\/p>\n\n\n\n<p>Takeda, with its rich history dating back to 2019 in Neuch\u00e2tel, post-acquisition of UK-based Shire, has been a pivotal player in global healthcare. The <a href=\"https:\/\/ggba.swiss\/en\/takeda-to-invest-chf-200-million-in-its-neuchatel-production-site\/\">company&#8217;s investment in expanding its production capabilities<\/a> and its dedication to innovation aligns with Atinary&#8217;s mission to expedite the discovery and development of breakthrough molecules and materials through its robust ML platform.<\/p>\n\n\n\n<p>The strategic collaboration between Atinary and Takeda is a landmark initiative that combines Atinary\u2019s prowess in AI, data science, robotics, and cloud computing with Takeda&#8217;s deep-rooted expertise in pharmaceutical R&amp;D. Together, they aim to unlock new possibilities in drug discovery, making strides towards developing treatments that could significantly impact patients&#8217; lives worldwide.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Atinary Technologies, a Vaud-based machine learning specialist, has joined forces with Takeda, Japan&#8217;s largest pharmaceutical entity, to spearhead innovation in healthcare.<\/p>\n","protected":false},"author":6,"featured_media":22737,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[833],"tags":[893,980,930,890,911,886],"class_list":["post-22736","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-life-science","tag-artificial-intelligence","tag-big-data-en","tag-digital-health","tag-healthcare","tag-pharma","tag-rd"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Atinary and Takeda together to advance healthcare innovation<\/title>\n<meta name=\"description\" content=\"Atinary Technologies has joined forces with Takeda, Japan&#039;s largest pharmaceutical entity, to spearhead innovation in healthcare.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/en\/atinary-and-takeda-forge-a-strategic-alliance-to-advance-healthcare-innovation\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Atinary and Takeda together to advance healthcare innovation\" \/>\n<meta property=\"og:description\" content=\"Atinary Technologies has joined forces with Takeda, Japan&#039;s largest pharmaceutical entity, to spearhead innovation in healthcare.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/en\/atinary-and-takeda-forge-a-strategic-alliance-to-advance-healthcare-innovation\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2024-02-19T13:40:31+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-02-19T13:40:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2024\/02\/Atinary-Takeda-Healthcare-2360x1622-1.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"2360\" \/>\n\t<meta property=\"og:image:height\" content=\"1622\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/en\/atinary-and-takeda-forge-a-strategic-alliance-to-advance-healthcare-innovation\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/en\/atinary-and-takeda-forge-a-strategic-alliance-to-advance-healthcare-innovation\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"Atinary and Takeda forge a strategic alliance to advance healthcare innovation\",\"datePublished\":\"2024-02-19T13:40:31+00:00\",\"dateModified\":\"2024-02-19T13:40:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/atinary-and-takeda-forge-a-strategic-alliance-to-advance-healthcare-innovation\/\"},\"wordCount\":229,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/atinary-and-takeda-forge-a-strategic-alliance-to-advance-healthcare-innovation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/02\/Atinary-Takeda-Healthcare-2360x1622-1.jpeg\",\"keywords\":[\"Artificial Intelligence\",\"Big Data\",\"Digital Health\",\"Healthcare\",\"Pharma\",\"R&amp;D\"],\"articleSection\":[\"Life sciences\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/en\/atinary-and-takeda-forge-a-strategic-alliance-to-advance-healthcare-innovation\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/en\/atinary-and-takeda-forge-a-strategic-alliance-to-advance-healthcare-innovation\/\",\"url\":\"https:\/\/ggba.swiss\/en\/atinary-and-takeda-forge-a-strategic-alliance-to-advance-healthcare-innovation\/\",\"name\":\"Atinary and Takeda together to advance healthcare innovation\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/atinary-and-takeda-forge-a-strategic-alliance-to-advance-healthcare-innovation\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/atinary-and-takeda-forge-a-strategic-alliance-to-advance-healthcare-innovation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/02\/Atinary-Takeda-Healthcare-2360x1622-1.jpeg\",\"datePublished\":\"2024-02-19T13:40:31+00:00\",\"dateModified\":\"2024-02-19T13:40:32+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"Atinary Technologies has joined forces with Takeda, Japan's largest pharmaceutical entity, to spearhead innovation in healthcare.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/en\/atinary-and-takeda-forge-a-strategic-alliance-to-advance-healthcare-innovation\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/en\/atinary-and-takeda-forge-a-strategic-alliance-to-advance-healthcare-innovation\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ggba.swiss\/en\/atinary-and-takeda-forge-a-strategic-alliance-to-advance-healthcare-innovation\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/02\/Atinary-Takeda-Healthcare-2360x1622-1.jpeg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/02\/Atinary-Takeda-Healthcare-2360x1622-1.jpeg\",\"width\":2360,\"height\":1622,\"caption\":\"This alliance between Atinary and Takeda is a shining example of how technology and healthcare can come together to create innovative solutions that address pressing challenges in drug development.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/en\/atinary-and-takeda-forge-a-strategic-alliance-to-advance-healthcare-innovation\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Atinary and Takeda forge a strategic alliance to advance healthcare innovation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/en\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Atinary and Takeda together to advance healthcare innovation","description":"Atinary Technologies has joined forces with Takeda, Japan's largest pharmaceutical entity, to spearhead innovation in healthcare.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/en\/atinary-and-takeda-forge-a-strategic-alliance-to-advance-healthcare-innovation\/","og_locale":"en_US","og_type":"article","og_title":"Atinary and Takeda together to advance healthcare innovation","og_description":"Atinary Technologies has joined forces with Takeda, Japan's largest pharmaceutical entity, to spearhead innovation in healthcare.","og_url":"https:\/\/ggba.swiss\/en\/atinary-and-takeda-forge-a-strategic-alliance-to-advance-healthcare-innovation\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2024-02-19T13:40:31+00:00","article_modified_time":"2024-02-19T13:40:32+00:00","og_image":[{"width":2360,"height":1622,"url":"https:\/\/ggba.swiss\/app\/uploads\/2024\/02\/Atinary-Takeda-Healthcare-2360x1622-1.jpeg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Pierre-Yves Oehrli","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/en\/atinary-and-takeda-forge-a-strategic-alliance-to-advance-healthcare-innovation\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/en\/atinary-and-takeda-forge-a-strategic-alliance-to-advance-healthcare-innovation\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"Atinary and Takeda forge a strategic alliance to advance healthcare innovation","datePublished":"2024-02-19T13:40:31+00:00","dateModified":"2024-02-19T13:40:32+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/en\/atinary-and-takeda-forge-a-strategic-alliance-to-advance-healthcare-innovation\/"},"wordCount":229,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/en\/atinary-and-takeda-forge-a-strategic-alliance-to-advance-healthcare-innovation\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/02\/Atinary-Takeda-Healthcare-2360x1622-1.jpeg","keywords":["Artificial Intelligence","Big Data","Digital Health","Healthcare","Pharma","R&amp;D"],"articleSection":["Life sciences"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/en\/atinary-and-takeda-forge-a-strategic-alliance-to-advance-healthcare-innovation\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/en\/atinary-and-takeda-forge-a-strategic-alliance-to-advance-healthcare-innovation\/","url":"https:\/\/ggba.swiss\/en\/atinary-and-takeda-forge-a-strategic-alliance-to-advance-healthcare-innovation\/","name":"Atinary and Takeda together to advance healthcare innovation","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/en\/atinary-and-takeda-forge-a-strategic-alliance-to-advance-healthcare-innovation\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/en\/atinary-and-takeda-forge-a-strategic-alliance-to-advance-healthcare-innovation\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/02\/Atinary-Takeda-Healthcare-2360x1622-1.jpeg","datePublished":"2024-02-19T13:40:31+00:00","dateModified":"2024-02-19T13:40:32+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"Atinary Technologies has joined forces with Takeda, Japan's largest pharmaceutical entity, to spearhead innovation in healthcare.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/en\/atinary-and-takeda-forge-a-strategic-alliance-to-advance-healthcare-innovation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/en\/atinary-and-takeda-forge-a-strategic-alliance-to-advance-healthcare-innovation\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ggba.swiss\/en\/atinary-and-takeda-forge-a-strategic-alliance-to-advance-healthcare-innovation\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2024\/02\/Atinary-Takeda-Healthcare-2360x1622-1.jpeg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/02\/Atinary-Takeda-Healthcare-2360x1622-1.jpeg","width":2360,"height":1622,"caption":"This alliance between Atinary and Takeda is a shining example of how technology and healthcare can come together to create innovative solutions that address pressing challenges in drug development."},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/en\/atinary-and-takeda-forge-a-strategic-alliance-to-advance-healthcare-innovation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/en\/"},{"@type":"ListItem","position":2,"name":"Atinary and Takeda forge a strategic alliance to advance healthcare innovation"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/en\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/22736","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/comments?post=22736"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/22736\/revisions"}],"predecessor-version":[{"id":22740,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/22736\/revisions\/22740"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media\/22737"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media?parent=22736"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/categories?post=22736"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/tags?post=22736"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}